Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
189.60
-4.62 (-2.38%)
At close: Oct 31, 2025, 4:00 PM EDT
187.00
-2.60 (-1.37%)
After-hours: Oct 31, 2025, 7:59 PM EDT
Insmed Market Cap
Insmed has a market cap or net worth of $40.44 billion as of October 31, 2025. Its market cap has increased by 215.17% in one year.
Market Cap
40.44B
Enterprise Value
39.50B
1-Year Change
215.17%
Ranking
Category
Stock Price
$189.60
Market Cap Chart
Since June 1, 2000, Insmed's market cap has increased from $445.50M to $40.44B, an increase of 8,976.69%. That is a compound annual growth rate of 19.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 41.05B | 232.38% |
| Dec 31, 2024 | 12.35B | 178.59% |
| Dec 29, 2023 | 4.43B | 63.79% |
| Dec 30, 2022 | 2.71B | -16.06% |
| Dec 31, 2021 | 3.22B | -4.92% |
| Dec 31, 2020 | 3.39B | 58.95% |
| Dec 31, 2019 | 2.13B | 110.95% |
| Dec 31, 2018 | 1.01B | -57.65% |
| Dec 29, 2017 | 2.39B | 191.73% |
| Dec 30, 2016 | 818.60M | -27.02% |
| Dec 31, 2015 | 1.12B | 46.00% |
| Dec 31, 2014 | 768.30M | 15.55% |
| Dec 31, 2013 | 664.90M | 217.07% |
| Dec 31, 2012 | 209.70M | 177.01% |
| Dec 30, 2011 | 75.70M | -7.91% |
| Dec 31, 2010 | 82.20M | -18.05% |
| Dec 31, 2009 | 100.30M | 75.35% |
| Dec 31, 2008 | 57.20M | -43.08% |
| Dec 31, 2007 | 100.50M | 13.95% |
| Dec 29, 2006 | 88.20M | -17.72% |
| Dec 30, 2005 | 107.20M | 26.86% |
| Dec 31, 2004 | 84.50M | -25.88% |
| Dec 31, 2003 | 114.00M | 665.10% |
| Dec 31, 2002 | 14.90M | -88.15% |
| Dec 31, 2001 | 125.70M | 10.94% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 236.67B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |